These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3962592)

  • 1. DNA-flow fluorescence--cytometry of ependymomas. Report on ten surgically removed tumours.
    Spaar FW; Blech M; Ahyai A
    Acta Neuropathol; 1986; 69(1-2):153-60. PubMed ID: 3962592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of claudins relates to tumour aggressivity, location and recurrence in ependymomas.
    Nordfors K; Haapasalo J; Sallinen PK; Haapasalo H; Soini Y
    Histol Histopathol; 2013 Sep; 28(9):1137-46. PubMed ID: 23423606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric DNA analysis of pediatric intracranial ependymomas.
    Kotylo PK; Robertson PB; Fineberg NS; Azzarelli B; Jakacki R
    Arch Pathol Lab Med; 1997 Dec; 121(12):1255-8. PubMed ID: 9431314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ependymomas in children: histologic and DNA-flow cytometric study.
    Reyes-Mugica M; Chou PM; Myint MM; Ridaura-Sanz C; Gonzalez-Crussi F; Tomita T
    Pediatr Pathol; 1994; 14(3):453-66. PubMed ID: 8066002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
    Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
    Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
    Suri VS; Tatke M; Singh D; Sharma A
    Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype.
    Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL
    Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supratentorial extraventricular ependymal neoplasms: a clinicopathologic study of 32 patients.
    Shuangshoti S; Rushing EJ; Mena H; Olsen C; Sandberg GD
    Cancer; 2005 Jun; 103(12):2598-605. PubMed ID: 15861411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clear cells are associated with proliferative activity in ependymoma: a quantitative study.
    Ishizawa K; Komori T; Aihara Y; Maruyama T; Okada Y; Ikuta S; Muragaki Y; Hirose T; Homma T; Sasaki A
    Clin Neuropathol; 2012; 31(3):146-51. PubMed ID: 22551919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated
    Ramsawhook A; Lewis L; Coyle B; Ruzov A
    Clin Epigenetics; 2017; 9():18. PubMed ID: 28228863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of stem cell marker nestin and its correlation with vascular endothelial growth factor and microvascular density in ependymomas.
    Nambirajan A; Sharma MC; Gupta RK; Suri V; Singh M; Sarkar C
    Neuropathol Appl Neurobiol; 2014 Oct; 40(6):714-25. PubMed ID: 24224478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of chromosome 22 and proliferative potential in ependymomas.
    Debiec-Rychter M; Biernat W; Zakrzewski K; Krul W; Liberski PP
    Folia Neuropathol; 2003; 41(4):191-5. PubMed ID: 14977248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade.
    Altura RA; Olshefski RS; Jiang Y; Boué DR
    Br J Cancer; 2003 Nov; 89(9):1743-9. PubMed ID: 14583779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and overexpression of mdm2 gene in ependymomas.
    Suzuki SO; Iwaki T
    Mod Pathol; 2000 May; 13(5):548-53. PubMed ID: 10824927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas.
    Singh PK; Gutmann DH; Fuller CE; Newsham IF; Perry A
    Mod Pathol; 2002 May; 15(5):526-31. PubMed ID: 12011257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression patterns in ependymomas correlate with tumor location, grade, and patient age.
    Korshunov A; Neben K; Wrobel G; Tews B; Benner A; Hahn M; Golanov A; Lichter P
    Am J Pathol; 2003 Nov; 163(5):1721-7. PubMed ID: 14578171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
    Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
    Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.
    Korshunov A; Golanov A; Timirgaz V
    J Neurol Sci; 2000 Aug; 177(1):72-82. PubMed ID: 10967185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flow cytometry in the evaluation of the prognosis and course of malignant soft-tissue tumors].
    Zubrikhina GN; Ol'khovskaia IG
    Arkh Patol; 1990; 52(9):29-33. PubMed ID: 2270977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytophotometric investigations of the nuclear DNA content in ependymomas and plexuspapillomas (author's transl)].
    Müller W; Brämisch R; Afra D; Schwenzfeger A
    Acta Neuropathol; 1977 Aug; 39(3):255-9. PubMed ID: 906808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.